Drug intelligence / Profile preview

berberis aristata extract

Development stage
Preclinical
Lead developer
Kerman University of Medical Sciences
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Berberis aristata extract, also known as Indian barberry or tree turmeric extract, is a botanical extract derived from the roots, bark, and stems of the *Berberis aristata* plant. It is highly valued in traditional Ayurvedic and Chinese medicine and is widely used as a dietary supplement and nutraceutical. The primary bioactive constituent of the extract is berberine, a quaternary isoquinoline alkaloid. Berberis aristata extract exhibits a multi-target mechanism of action, primarily characterized by the indirect activation of AMP-activated protein kinase (AMPK) via the inhibition of mitochondrial respiratory chain complex I, as well as the direct inhibition of dipeptidyl peptidase 4 (DPP4). These pathways contribute to its significant glucose-lowering, lipid-lowering, anti-inflammatory, and hepatoprotective properties. The extract is primarily investigated and used for metabolic disorders, including type 2 diabetes mellitus, prediabetes, hyperlipidemia, and non-alcoholic fatty liver disease (NAFLD), as well as mild cognitive impairment.

Other names
Berberis aristata bark extractBerberis aristata root extractDaruharidra extractIndian barberry extracttree turmeric extract
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)BACE1 (Beta-site APP-cleaving enzyme 1)DPP-4 (Dipeptidyl Peptidase-IV)NDUFS1NEK7 (NIMA-related kinase 7)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)PCSK9 (Proprotein convertase subtilisin/kexin type 9)

Beyond the preview

Go deeper on berberis aristata extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on berberis aristata extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call